BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32193367)

  • 1. Experimental Study of Somatic Variants of Osteosarcoma by Whole-Exome Sequencing.
    Hou J; Liu G; Zhang P; Wang B; Yan Q; Wu P; Wang C; Yao W
    Med Sci Monit; 2020 Mar; 26():e920826. PubMed ID: 32193367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases.
    Wang D; Niu X; Wang Z; Song CL; Huang Z; Chen KN; Duan J; Bai H; Xu J; Zhao J; Wang Y; Zhuo M; Xie XS; Kang X; Tian Y; Cai L; Han JF; An T; Sun Y; Gao S; Zhao J; Ying J; Wang L; He J; Wang J
    Cancer Res; 2019 Jan; 79(1):7-20. PubMed ID: 30389703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mutation characteristics of osteosarcoma: a single center study of 64 cases using next-generation sequencing].
    Gao DL; Dong RF; Liu WF; Gong LH; Xu HR; Niu XH; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):370-375. PubMed ID: 36973198
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific genetic aberrations of parathyroid in Chinese patients with tertiary hyperparathyroidism using whole-exome sequencing.
    Li L; Sheng Q; Zeng H; Li W; Wang Q; Ma G; Xu X; Qiu M; Zhang W; Shan C
    Front Endocrinol (Lausanne); 2023; 14():1221060. PubMed ID: 37854190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome sequencing analysis of blood cells identifies germline haplotypes strongly associated with drug resistance in osteosarcoma patients.
    Bhuvaneshwar K; Harris M; Gusev Y; Madhavan S; Iyer R; Vilboux T; Deeken J; Yang E; Shankar S
    BMC Cancer; 2019 Apr; 19(1):357. PubMed ID: 30991985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole exome sequencing of a single osteosarcoma case--integrative analysis with whole transcriptome RNA-seq data.
    Reimann E; Kõks S; Ho XD; Maasalu K; Märtson A
    Hum Genomics; 2014 Dec; 8(1):20. PubMed ID: 25496518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations.
    Bousquet M; Noirot C; Accadbled F; Sales de Gauzy J; Castex MP; Brousset P; Gomez-Brouchet A
    Ann Oncol; 2016 Apr; 27(4):738-44. PubMed ID: 26787232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma.
    Negri GL; Grande BM; Delaidelli A; El-Naggar A; Cochrane D; Lau CC; Triche TJ; Moore RA; Jones SJ; Montpetit A; Marra MA; Malkin D; Morin RD; Sorensen PH
    J Pathol; 2019 Nov; 249(3):319-331. PubMed ID: 31236944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized combination therapies based on whole-exome sequencing displayed significant clinical benefits in a glioblastoma patient with secondary osteosarcoma: case report and genetic characterization.
    Yi GZ; Zhu TC; Que TS; Li ZY; Huang GL
    BMC Neurol; 2022 Oct; 22(1):390. PubMed ID: 36271359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenes.
    Choy E; Hornicek F; MacConaill L; Harmon D; Tariq Z; Garraway L; Duan Z
    Cancer; 2012 Jun; 118(11):2905-14. PubMed ID: 22006429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways.
    Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ
    Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.
    Chen X; Bahrami A; Pappo A; Easton J; Dalton J; Hedlund E; Ellison D; Shurtleff S; Wu G; Wei L; Parker M; Rusch M; Nagahawatte P; Wu J; Mao S; Boggs K; Mulder H; Yergeau D; Lu C; Ding L; Edmonson M; Qu C; Wang J; Li Y; Navid F; Daw NC; Mardis ER; Wilson RK; Downing JR; Zhang J; Dyer MA;
    Cell Rep; 2014 Apr; 7(1):104-12. PubMed ID: 24703847
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Sakthikumar S; Elvers I; Kim J; Arendt ML; Thomas R; Turner-Maier J; Swofford R; Johnson J; Schumacher SE; Alföldi J; Axelsson E; Couto CG; Kisseberth WC; Pettersson ME; Getz G; Meadows JRS; Modiano JF; Breen M; Kierczak M; Forsberg-Nilsson K; Marinescu VD; Lindblad-Toh K
    Cancer Res; 2018 Jul; 78(13):3421-3431. PubMed ID: 29724721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency.
    Kovac M; Blattmann C; Ribi S; Smida J; Mueller NS; Engert F; Castro-Giner F; Weischenfeldt J; Kovacova M; Krieg A; Andreou D; Tunn PU; Dürr HR; Rechl H; Schaser KD; Melcher I; Burdach S; Kulozik A; Specht K; Heinimann K; Fulda S; Bielack S; Jundt G; Tomlinson I; Korbel JO; Nathrath M; Baumhoer D
    Nat Commun; 2015 Dec; 6():8940. PubMed ID: 26632267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics and the Immune Landscape of Osteosarcoma.
    Wu CC; Livingston JA
    Adv Exp Med Biol; 2020; 1258():21-36. PubMed ID: 32767232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine.
    Subbiah V; Wagner MJ; McGuire MF; Sarwari NM; Devarajan E; Lewis VO; Westin S; Kato S; Brown RE; Anderson P
    Oncotarget; 2015 Dec; 6(38):40642-54. PubMed ID: 26510912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of Candidate Pathogenic Genes for Spontaneous Abortion Using Whole Exome Sequencing.
    Zhu Q; Liu J; Chen L; Zhou Y; Zhou T; Bian W; Ding G; Li G; Ding J
    Comb Chem High Throughput Screen; 2022; 25(9):1462-1473. PubMed ID: 34225611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of New Potential Prognostic and Predictive Markers in High-Grade Osteosarcoma Using Whole Exome Sequencing.
    Gaeta R; Morelli M; Lessi F; Mazzanti CM; Menicagli M; Capanna R; Andreani L; Coccoli L; Aretini P; Franchi A
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of osteosarcoma.
    Rickel K; Fang F; Tao J
    Bone; 2017 Sep; 102():69-79. PubMed ID: 27760307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.
    Lasorsa VA; Formicola D; Pignataro P; Cimmino F; Calabrese FM; Mora J; Esposito MR; Pantile M; Zanon C; De Mariano M; Longo L; Hogarty MD; de Torres C; Tonini GP; Iolascon A; Capasso M
    Oncotarget; 2016 Apr; 7(16):21840-52. PubMed ID: 27009842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.